Early treatment with dipeptidyl-peptidase 4 inhibitors reduces glycaemic variability and delays insulin initiation in type 2 diabetes: A propensity score-matched cohort study.
Johnny T K CheungAimin YangHongjiang WuEric S H LauAlice P S KongRonald Ching-Wan MaAndrea On Yan LukJuliana Chung Ngor ChanElaine ChowPublished in: Diabetes/metabolism research and reviews (2023)
In type 2 diabetes, early DPP4i intensification delayed insulin initiation, partially explained by reduced glycaemic variability.